Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Fresenius Medical Care AG Co. KGaA (FMS - Free Report) : This company that provides products and services for individuals undergoing dialysis following chronic kidney failure has seen the Zacks Consensus Estimate for its current year earnings increasing 13.7% over the last 60 days.
Owens Corning Inc (OC - Free Report) : This world leader in building materials systems and composite solutions has seen the Zacks Consensus Estimate for its current year earnings increasing 33.2% over the last 60 days.
Penske Automotive Group, Inc. (PAG - Free Report) : This company that engages in the operation of automotive and commercial truck dealerships has seen the Zacks Consensus Estimate for its current year earnings increasing 27.1% over the last 60 days.
Sanmina Corporation (SANM - Free Report) : This company that provides electronics contract manufacturing services has seen the Zacks Consensus Estimate for its current year earnings increasing 43.7% over the last 60 days.
Werner Enterprises, Inc. (WERN - Free Report) : This transportation and logistics company has seen the Zacks Consensus Estimate for its current year earnings increasing 9.9% over the last 60 days.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Fresenius Medical Care AG Co. KGaA (FMS - Free Report) : This company that provides products and services for individuals undergoing dialysis following chronic kidney failure has seen the Zacks Consensus Estimate for its current year earnings increasing 13.7% over the last 60 days.
Owens Corning Inc (OC - Free Report) : This world leader in building materials systems and composite solutions has seen the Zacks Consensus Estimate for its current year earnings increasing 33.2% over the last 60 days.
Penske Automotive Group, Inc. (PAG - Free Report) : This company that engages in the operation of automotive and commercial truck dealerships has seen the Zacks Consensus Estimate for its current year earnings increasing 27.1% over the last 60 days.
Sanmina Corporation (SANM - Free Report) : This company that provides electronics contract manufacturing services has seen the Zacks Consensus Estimate for its current year earnings increasing 43.7% over the last 60 days.
Werner Enterprises, Inc. (WERN - Free Report) : This transportation and logistics company has seen the Zacks Consensus Estimate for its current year earnings increasing 9.9% over the last 60 days.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on PAG - FREE
Get the latest research report on FMS - FREE
Get the latest research report on SANM - FREE
Get the latest research report on OC - FREE
Get the latest research report on WERN - FREE